X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CELLULAR ONCOLOGY

期刊標題檢索 最新評論: This magazine website claims to be a mix of OA and non-OA, why is th... (2024-11-07)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CELLULAR ONCOLOGY]您好,您是該頁面的第 31536 位訪客。

期刊簡介
期刊名稱CELLULAR ONCOLOGY CELLULAR ONCOLOGY
LetPub Score
6.5
50 ratings
Rate

Reputation
7.8

Influence
5.3

Speed
7.0

期刊簡稱
ISSN1570-5870
E-ISSN2211-3436
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
10.301.4891.031
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q156 / 404
Category: Medicine
Subcategory: Molecular Medicine
Q132 / 178
Category: Medicine
Subcategory: Cancer Research
Q148 / 230

自引率 (2023-2024)2.00%自引率趨勢
掲載範囲
The Official Journal of the International Society for Cellular Oncology
Focuses on translational research
Addresses the conversion of cell biology to clinical applications
Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions.

A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients.
In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations.
官方網站https://www.springer.com/13402
在線稿件提交https://www.editorialmanager.com/ceon
開放訪問No
出版商Springer Netherlands
主題領域Biochemistry, Genetics and Molecular Biology
出版國/地區NETHERLANDS
發行頻率隔月刊行
創刊年2011
每年文章數136每年文章數趨勢
黃金OA百分比29.94%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ267/205
ONCOLOGYSCIEQ168/322
PATHOLOGYSCIEQ111/88
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1570-5870%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 16 Weeks
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【CELLULAR ONCOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Cancer CommunicationsH-index: 0

    CiteScore: 25.50
    Translational OncologyH-index: 41

    CiteScore: 8.40
    Frontiers in OncologyH-index: 60

    CiteScore: 6.20
    Journal of Gastric CancerH-index: 22

    CiteScore: 4.30
    Molecular and Cellular OncologyH-index: 0

    CiteScore: 3.20
    Clinical and Experimental MorphologyH-index: 0

    CiteScore: 0.60
    Critical Reviews in OncogenesisH-index: 0

    CiteScore: 1.70
    International Journal of Medical BiochemistryH-index: 0

    CiteScore: 0.50
    Advances in Cancer Biology MetastasisH-index: 0

    CiteScore: 2.40
    學科內最受檢索的期刊 頁面查看次數
    Frontiers in Oncology415879
    Translational Oncology65725
    Cancer Communications55531
    Journal of Gastric Cancer16502
    Molecular and Cellular Oncology4959
    Critical Reviews in Oncogenesis3599
    Clinical and Experimental Morphology2583
    Advances in Cancer Biology Metastasis758
    International Journal of Medical Biochemistry631
  •  

    CELLULAR ONCOLOGY CELLULAR ONCOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CELLULAR ONCOLOGY] 的評論撰寫評論
作者: jianghong2


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-07 16:59:55 評論於
This magazine website claims to be a mix of OA and non-OA, why is there only one option when submitting a paper, and you can only choose to accept APC.
(0) 讚! | jianghong2

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CELLULAR ONCOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*